0.00 900.00
Prev Close 0.00
Open 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.01
Volume 500.00
Exchange OTC
Shares Outstanding 53.64B
Market Cap 53.60K
Div & Yield N.A. (N.A)

For Myriad Genetics, the Splice Is Right

Myriad Genetics shares were soaring Tuesday after the firm announced a healthy second quarter that beat analyst expectations.

Biotech Stock Mailbag: Panacos

Panacos is worth more than 12 cents -- and is worth hanging on to.

Biotech Mailbag: Savient's Unsavory Surprise

Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.

Feuerstein's Biotech-Stock Mailbag: Panacos

Confessions of a former Panacostal; weighing Indevus' chances after its latest FDA blow; and more Elan.

Biotech Notebook: Medarex, Panacos, Advanced Life

Medarex refuses to face reality about the trial failure of its skin cancer drug.

Friday's Health Winners & Losers

Immucor slumps on an FTC investigation.

Thursday's Late Winners & Losers

Microsoft led the after-hours charge, following an earnings beat.

Feuerstein's Biotech-Stock Mailbag

This week: Biogen Idec and Neurocrine Biosciences.

Tuesday's Health Winners & Losers

Panacos falls on the departure of its CFO as well as a downgrade.

Tuesday's Small-Cap Winners & Losers

McCormick & Schmick's slides on lowered guidance.

Panacos Pharma CFO Resigns

Peyton Marshall leaves to 'pursue other opportunities.'

Biotech Dustbin Yields Winners

Abandoned by investors, Genelabs and Panacos Pharma are worth a second look.

Wednesday's Late Winners & Losers

Hoku Scientific climbs on news of a signed contracted.

Avexa Data's Ripple Effect

Positive results from Australia could mean big things in the U.S.

Tuesday's Early Winners & Losers

Wireless Facilities falls after saying it needs to restate results.

Fretting Dow Theory

FedEx's miss gets folks worried about 'non confirmation'. Plus, the M&A wave rolls on.

Wednesday's Early Winners & Losers

Panacos falls on disappointing study data for its HIV treatment.

Thursday's Health Winners & Losers

Shares of Anadys Pharmaceuticals drop after the company announces the planned departure of its CEO.

Today's Early Winners and Losers

Charles & Colvard issues a first-quarter sales warning, sending shares sliding.

Health Stocks in Motion

Wright Medical falls following the resignation of its CEO.

Cramer's 'Mad Money Lightning Round': Not Calling Avon

Also, Banco Bradesco is muy caliente.

Cramer's 'Mad Money Lightning Round': Dell's a Tough Call

Cramer says it's worth waiting for this stock to drop down before buying.

Brazilian Storm Clouds Lift, for Now

There's little fallout Monday from a scandal that rocked the nation's financial markets Friday.

Health Stocks in Motion

Biolase believes shareholders will be better served by eliminating its dividend.